267 Shrewsbury St, Worcester, MA 01604-4623
This exceptional 11,940 square foot medical office building in Worcester, MA, presents a compelling investment opportunity. Priced at $4,400,000, it boasts a strong 6.62% cap rate, secured by a long-term lease. The property sits on a 0.46-acre lot in a highly attractive retail corridor. The lease agreement is a 15-year contract with approximately 8 years remaining, providing significant lease stability. Crucially, the lease includes a corporate guarantee from DaVita Inc., a company with $17 billion in assets and an S&P rating of "BB". This robust guarantee significantly mitigates investment risk. Further enhancing the investment's appeal are the built-in rental increases of 10% every five years, ensuring consistent growth in rental income. This property offers a rare combination of secure, long-term income, substantial corporate backing, and built-in appreciation potential, making it an ideal addition to any diversified investment portfolio. The prime location within a thriving retail area adds further value, promising strong future prospects. This is a turnkey investment opportunity with minimal management requirements and substantial upside potential. The property's strong fundamentals and secure lease make it an attractive option for discerning investors seeking stable, high-yield returns.
-
DaVita Shrewsbury Street Dialysis Medical Clinic
-
DaVita Shrewsbury Street At Home Medical Clinic
Cap rate
Implied · in-place · derived from last sale + estimated NOIValue
AI, CAP & Alternative Use estimations · Realmo proprietary blendProperty tax & assessments
Tax year 2024Comparables
6 recent transactions · within 1.5 miComparable in this City
Similar Nearby for Sale
Property description
Physical attributes from public recordsZoning & alternative use
MG-2 · Worcester, MAWorcester. Always verify with local authorities before improvements.
Costs & Benchmarks
Operating expenses, capex projections, utility benchmarks, and submarket comparables — all in one view.
Risks
Flood, climate, environmental, title, and tenant-concentration risk — surfaced with mitigations and source citations.